oral prolonged-release dienogest 2 mg and ethinylestradiol 0.02 mg in a 24/4-day regimen

Research studies on oral prolonged-release dienogest 2 mg and ethinylestradiol 0.02 mg in a 24/4-day regimen - conditions it treats, mechanisms of action, and clinical outcomes from peer-reviewed literature.